Cyclosporine enhances the sensitivity to lenalidomide in MDS/AML in vitro-Reference-Cited by-同舟云学术

Cyclosporine enhances the sensitivity to lenalidomide in MDS/AML in vitro

Published:2020-06 Issue: Volume:86 Page:21-27.e2
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

He Xiaofei,Dou Aixia,Feng Saran,Roman-Rivera Ashley,Hawkins Caleb,Lawley Lauren,Zhang Jiajia,Wunderlich Mark,Mizukawa Benjamin,Halene Stephanie,Patel Amisha,Fang Jing

Funder

National Institutes of Health

National Science Foundation

University of South Carolina

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference16 articles.

1. The application and biology of immunomodulatory drugs (IMiDs) in cancer;Pan;Pharmacol Ther,2012

2. Outcome of patients with acute myeloid leukemia with monosomal karyotype who undergo hematopoietic cell transplantation;Fang;Blood,2011

3. Pretreatment cytogenetics add to other prognostic factors predicting complete remission and long-term outcome in patients 60 years of age or older with acute myeloid leukemia: results from Cancer and Leukemia Group B 8461;Farag;Blood,2006

4. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells;Krönke;Science,2014

5. The myeloma drug lenalidomide promotes the cereblon-dependent destruction of Ikaros proteins;Lu;Science,2014

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myelodysplastic syndromes del(5q): Pathogenesis and its therapeutic implications;European Journal of Haematology;2024-01-31

2. LAM fatale ?;médecine/sciences;2023-06

3. Reshaping the tumor microenvironment: The versatility of immunomodulatory drugs in B-cell neoplasms;Frontiers in Immunology;2022-10-12

4. RCAN1-mediated calcineurin inhibition as a target for cancer therapy;Molecular Medicine;2022-06-18

5. Put in a “Ca2+ll” to Acute Myeloid Leukemia;Cells;2022-02-04